1 Study Coverage

• 1.1 Saliva-based Screening Revenue in Saliva-based Screening Business (2017-2022) & (US$ Million) Introduction
• 1.2 Global Saliva-based Screening Outlook 2017 VS 2022 VS 2028
• 1.2.1 Global Saliva-based Screening Market Size for the Year 2017-2028

1.2.2 Global Saliva-based Screening Market Size for the Year 2017-2028

1.3 Saliva-based Screening Market Size, United States VS Global, 2017 VS 2022 VS 2028

1.3.1 The Market Share of United States Saliva-based Screening in Global, 2017 VS 2022 VS 2028

1.3.2 The Growth Rate of Saliva-based Screening Market Size, United States VS Global, 2017 VS 2022 VS 2028

1.4 Saliva-based Screening Market Dynamics

1.4.1 Saliva-based Screening Industry Trends

1.4.2 Saliva-based Screening Market Drivers

1.4.3 Saliva-based Screening Market Challenges

1.4.4 Saliva-based Screening Market Restraints

1.5 Study Objectives

1.6 Years Considered

2 Saliva-based Screening by Type

• 2.1 Saliva-based Screening Market Segment by Type
• 2.1.1 Direct Sample to PCR

2.1.2 RT-qPCR

2.1.3 Lateral Flow Assays

2.2 Global Saliva-based Screening Market Size by Type (2017, 2022 & 2028)

2.3 Global Saliva-based Screening Market Size by Type (2017-2028)

2.4 United States Saliva-based Screening Market Size by Type (2017, 2022 & 2028)

2.5 United States Saliva-based Screening Market Size by Type (2017-2028)

3 Saliva-based Screening by Application

• 3.1 Saliva-based Screening Market Segment by Application
• 3.1.1 Diagnostic Laboratories

3.1.2 Hospitals & Clinics

3.1.3 Others

3.2 Global Saliva-based Screening Market Size by Application (2017, 2022 & 2028)

3.3 Global Saliva-based Screening Market Size by Application (2017-2028)

3.4 United States Saliva-based Screening Market Size by Application (2017, 2022 & 2028)

3.5 United States Saliva-based Screening Market Size by Application (2017-2028)

4 Global Saliva-based Screening Competitor Landscape by Company

• 4.1 Global Saliva-based Screening Market Size by Company
• 4.1.1 Top Global Saliva-based Screening Companies Ranked by Revenue (2021)

4.1.2 Global Saliva-based Screening Revenue by Player (2017-2022)

4.2 Global Saliva-based Screening Concentration Ratio (CR)

4.2.1 Saliva-based Screening Market Concentration Ratio (CR) (2017-2022)

4.2.2 Global Top 5 and Top 10 Largest Companies of Saliva-based Screening in 2021

4.2.3 Global Saliva-based Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.3 Global Saliva-based Screening Headquarters, Revenue in Saliva-based Screening Business (2017-2022) & (US$ Million) Type

4.3.1 Global Saliva-based Screening Headquarters and Area Served

4.3.2 Global Saliva-based Screening Companies Revenue in Saliva-based Screening Business (2017-2022) & (US$ Million) Type

4.3.3 Date of International Companies Enter into Saliva-based Screening Market

4.4 Companies Mergers & Acquisitions, Expansion Plans

4.5 United States Saliva-based Screening Market Size by Company

4.5.1 Top Saliva-based Screening Players in United States, Ranked by Revenue (2021)

4.5.2 United States Saliva-based Screening Revenue by Players (2020, 2021 & 2022)

5 Global Saliva-based Screening Market Size by Region

• 5.1 Global Saliva-based Screening Market Size by Region: 2017 VS 2022 VS 2028
• 5.2 Global Saliva-based Screening Market Size by Region (2017-2028)
• 5.2.1 Global Saliva-based Screening Market Size by Region: 2017-2022

5.2.2 Global Saliva-based Screening Market Size by Region (2023-2028)

6 Segment in Region Level & Country Level

• 6.1 North America
• 6.1.1 North America Saliva-based Screening Market Size YoY Growth 2017-2028

6.1.2 North America Saliva-based Screening Market Facts & Figures by Country (2017, 2022 & 2028)

6.1.3 United States

6.1.4 Canada

6.2 Asia-Pacific

6.2.1 Asia-Pacific Saliva-based Screening Market Size YoY Growth 2017-2028

6.2.2 Asia-Pacific Saliva-based Screening Market Facts & Figures by Region (2017, 2022 & 2028)

6.2.3 China

6.2.4 Japan

6.2.5 South Korea

6.2.6 India

6.2.7 Australia

6.2.8 China Taiwan

6.2.9 Indonesia

6.2.10 Thailand

6.2.11 Malaysia

6.3 Europe

6.3.1 Europe Saliva-based Screening Market Size YoY Growth 2017-2028

6.3.2 Europe Saliva-based Screening Market Facts & Figures by Country (2017, 2022 & 2028)

6.3.3 Germany

6.3.4 France

6.3.5 U.K.

6.3.6 Italy

6.3.7 Russia

6.4 Latin America

6.4.1 Latin America Saliva-based Screening Market Size YoY Growth 2017-2028

6.4.2 Latin America Saliva-based Screening Market Facts & Figures by Country (2017, 2022 & 2028)

6.4.3 Mexico

6.4.4 Brazil

6.4.5 Argentina

6.5 Middle East and Africa

6.5.1 Middle East and Africa Saliva-based Screening Market Size YoY Growth 2017-2028

6.5.2 Middle East and Africa Saliva-based Screening Market Facts & Figures by Country (2017, 2022 & 2028)

6.5.3 Turkey

6.5.4 Saudi Arabia

6.5.5 UAE

7 Company Profiles

• 7.1 Thermo Fisher scientific
• 7.1.1 Thermo Fisher scientific Company Details

7.1.2 Thermo Fisher scientific Business Overview

7.1.3 Thermo Fisher scientific Saliva-based Screening Introduction

7.1.4 Thermo Fisher scientific Revenue in Saliva-based Screening Business (2017-2022)

7.1.5 Thermo Fisher scientific Recent Development

7.2 Qiagen

7.2.1 Qiagen Company Details

7.2.2 Qiagen Business Overview

7.2.3 Qiagen Saliva-based Screening Introduction

7.2.4 Qiagen Revenue in Saliva-based Screening Business (2017-2022)

7.2.5 Qiagen Recent Development

7.3 Hologic

7.3.1 Hologic Company Details

7.3.2 Hologic Business Overview

7.3.3 Hologic Saliva-based Screening Introduction

7.3.4 Hologic Revenue in Saliva-based Screening Business (2017-2022)

7.3.5 Hologic Recent Development

7.4 Takara Bio Inc

7.4.1 Takara Bio Inc Company Details

7.4.2 Takara Bio Inc Business Overview

7.4.3 Takara Bio Inc Saliva-based Screening Introduction

7.4.4 Takara Bio Inc Revenue in Saliva-based Screening Business (2017-2022)

7.4.5 Takara Bio Inc Recent Development

7.5 Arcis Biotechnology Limited

7.5.1 Arcis Biotechnology Limited Company Details

7.5.2 Arcis Biotechnology Limited Business Overview

7.5.3 Arcis Biotechnology Limited Saliva-based Screening Introduction

7.5.4 Arcis Biotechnology Limited Revenue in Saliva-based Screening Business (2017-2022)

7.5.5 Arcis Biotechnology Limited Recent Development

7.6 GeneProof

7.6.1 GeneProof Company Details

7.6.2 GeneProof Business Overview

7.6.3 GeneProof Saliva-based Screening Introduction

7.6.4 GeneProof Revenue in Saliva-based Screening Business (2017-2022)

7.6.5 GeneProof Recent Development

7.7 Abacus ALS

7.7.1 Abacus ALS Company Details

7.7.2 Abacus ALS Business Overview

7.7.3 Abacus ALS Saliva-based Screening Introduction

7.7.4 Abacus ALS Revenue in Saliva-based Screening Business (2017-2022)

7.7.5 Abacus ALS Recent Development

7.8 Chai Inc.

7.8.1 Chai Inc. Company Details

7.8.2 Chai Inc. Business Overview

7.8.3 Chai Inc. Saliva-based Screening Introduction

7.8.4 Chai Inc. Revenue in Saliva-based Screening Business (2017-2022)

7.8.5 Chai Inc. Recent Development

7.9 Kolplast Group

7.9.1 Kolplast Group Company Details

7.9.2 Kolplast Group Business Overview

7.9.3 Kolplast Group Saliva-based Screening Introduction

7.9.4 Kolplast Group Revenue in Saliva-based Screening Business (2017-2022)

7.9.5 Kolplast Group Recent Development

7.10 Lucence Health INc

7.10.1 Lucence Health INc Company Details

7.10.2 Lucence Health INc Business Overview

7.10.3 Lucence Health INc Saliva-based Screening Introduction

7.10.4 Lucence Health INc Revenue in Saliva-based Screening Business (2017-2022)

7.10.5 Lucence Health INc Recent Development

7.11 Vitagene

7.11.1 Vitagene Company Details

7.11.2 Vitagene Business Overview

7.11.3 Vitagene Saliva-based Screening Introduction

7.11.4 Vitagene Revenue in Saliva-based Screening Business (2017-2022)

7.11.5 Vitagene Recent Development

7.12 Therma Bright Inc

7.12.1 Therma Bright Inc Company Details

7.12.2 Therma Bright Inc Business Overview

7.12.3 Therma Bright Inc Saliva-based Screening Introduction

7.12.4 Therma Bright Inc Revenue in Saliva-based Screening Business (2017-2022)

7.12.5 Therma Bright Inc Recent Development

7.13 ACON Laboratories, Inc

7.13.1 ACON Laboratories, Inc Company Details

7.13.2 ACON Laboratories, Inc Business Overview

7.13.3 ACON Laboratories, Inc Saliva-based Screening Introduction

7.13.4 ACON Laboratories, Inc Revenue in Saliva-based Screening Business (2017-2022)

7.13.5 ACON Laboratories, Inc Recent Development

7.14 TODA PHARMA

7.14.1 TODA PHARMA Company Details

7.14.2 TODA PHARMA Business Overview

7.14.3 TODA PHARMA Saliva-based Screening Introduction

7.14.4 TODA PHARMA Revenue in Saliva-based Screening Business (2017-2022)

7.14.5 TODA PHARMA Recent Development

7.15 Norgen Biotek Corp.

7.15.1 Norgen Biotek Corp. Company Details

7.15.2 Norgen Biotek Corp. Business Overview

7.15.3 Norgen Biotek Corp. Saliva-based Screening Introduction

7.15.4 Norgen Biotek Corp. Revenue in Saliva-based Screening Business (2017-2022)

7.15.5 Norgen Biotek Corp. Recent Development

7.16 Assure Tech. (Hangzhou) Co., Ltd

7.16.1 Assure Tech. (Hangzhou) Co., Ltd Company Details

7.16.2 Assure Tech. (Hangzhou) Co., Ltd Business Overview

7.16.3 Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Introduction

7.16.4 Assure Tech. (Hangzhou) Co., Ltd Revenue in Saliva-based Screening Business (2017-2022)

7.16.5 Assure Tech. (Hangzhou) Co., Ltd Recent Development

7.17 Beijing Hotgen Biotech Co., Ltd

7.17.1 Beijing Hotgen Biotech Co., Ltd Company Details

7.17.2 Beijing Hotgen Biotech Co., Ltd Business Overview

7.17.3 Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Introduction

7.17.4 Beijing Hotgen Biotech Co., Ltd Revenue in Saliva-based Screening Business (2017-2022)

7.17.5 Beijing Hotgen Biotech Co., Ltd Recent Development

7.18 Nantong Diagnos Biotechnology Co., Ltd

7.18.1 Nantong Diagnos Biotechnology Co., Ltd Company Details

7.18.2 Nantong Diagnos Biotechnology Co., Ltd Business Overview

7.18.3 Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Introduction

7.18.4 Nantong Diagnos Biotechnology Co., Ltd Revenue in Saliva-based Screening Business (2017-2022)

7.18.5 Nantong Diagnos Biotechnology Co., Ltd Recent Development

7.19 NeuMoDx Molecular, Inc.

7.19.1 NeuMoDx Molecular, Inc. Company Details

7.19.2 NeuMoDx Molecular, Inc. Business Overview

7.19.3 NeuMoDx Molecular, Inc. Saliva-based Screening Introduction

7.19.4 NeuMoDx Molecular, Inc. Revenue in Saliva-based Screening Business (2017-2022)

7.19.5 NeuMoDx Molecular, Inc. Recent Development

7.20 KYODO INTERNATIONAL INC.

7.20.1 KYODO INTERNATIONAL INC. Company Details

7.20.2 KYODO INTERNATIONAL INC. Business Overview

7.20.3 KYODO INTERNATIONAL INC. Saliva-based Screening Introduction

7.20.4 KYODO INTERNATIONAL INC. Revenue in Saliva-based Screening Business (2017-2022)

7.20.5 KYODO INTERNATIONAL INC. Recent Development

7.21 Canvax

7.21.1 Canvax Company Details

7.21.2 Canvax Business Overview

7.21.3 Canvax Saliva-based Screening Introduction

7.21.4 Canvax Revenue in Saliva-based Screening Business (2017-2022)

7.21.5 Canvax Recent Development

7.22 Zymo Research Corporation.

7.22.1 Zymo Research Corporation. Company Details

7.22.2 Zymo Research Corporation. Business Overview

7.22.3 Zymo Research Corporation. Saliva-based Screening Introduction

7.22.4 Zymo Research Corporation. Revenue in Saliva-based Screening Business (2017-2022)

7.22.5 Zymo Research Corporation. Recent Development

7.23 Salimetrics

7.23.1 Salimetrics Company Details

7.23.2 Salimetrics Business Overview

7.23.3 Salimetrics Saliva-based Screening Introduction

7.23.4 Salimetrics Revenue in Saliva-based Screening Business (2017-2022)

7.23.5 Salimetrics Recent Development

7.24 NEST Scientific USA

7.24.1 NEST Scientific USA Company Details

7.24.2 NEST Scientific USA Business Overview

7.24.3 NEST Scientific USA Saliva-based Screening Introduction

7.24.4 NEST Scientific USA Revenue in Saliva-based Screening Business (2017-2022)

7.24.5 NEST Scientific USA Recent Development

7.25 Miraclean Technology Co. Ltd

7.25.1 Miraclean Technology Co. Ltd Company Details

7.25.2 Miraclean Technology Co. Ltd Business Overview

7.25.3 Miraclean Technology Co. Ltd Saliva-based Screening Introduction

7.25.4 Miraclean Technology Co. Ltd Revenue in Saliva-based Screening Business (2017-2022)

7.25.5 Miraclean Technology Co. Ltd Recent Development

7.26 Mawi DNA Technologies

7.26.1 Mawi DNA Technologies Company Details

7.26.2 Mawi DNA Technologies Business Overview

7.26.3 Mawi DNA Technologies Saliva-based Screening Introduction

7.26.4 Mawi DNA Technologies Revenue in Saliva-based Screening Business (2017-2022)

7.26.5 Mawi DNA Technologies Recent Development

7.27 Cell Projects Ltd.

7.27.1 Cell Projects Ltd. Company Details

7.27.2 Cell Projects Ltd. Business Overview

7.27.3 Cell Projects Ltd. Saliva-based Screening Introduction

7.27.4 Cell Projects Ltd. Revenue in Saliva-based Screening Business (2017-2022)

7.27.5 Cell Projects Ltd. Recent Development

8 Research Findings and Conclusion

9 Appendix

• 9.1 Research Methodology
• 9.1.1 Methodology/Research Approach

9.1.2 Data Source

9.2 Author Details

Market Analysis and Insights: Global and United States Saliva-based Screening Market
This report focuses on global and United States Saliva-based Screening market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Saliva-based Screening market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Direct Sample to PCR accounting for % of the Saliva-based Screening global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Diagnostic Laboratories was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.

In United States the Saliva-based Screening market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

Global Saliva-based Screening Scope and Market Size

Saliva-based Screening market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Saliva-based Screening market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Saliva-based Screening market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type, the Saliva-based Screening market is segmented into

Direct Sample to PCR

RT-qPCR

Lateral Flow Assays

Segment by Application, the Saliva-based Screening market is segmented into

Diagnostic Laboratories

Hospitals & Clinics

Others

Regional and Country-level Analysis

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Landscape and Saliva-based Screening Market Share Analysis

Saliva-based Screening market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Saliva-based Screening business, the date to enter into the Saliva-based Screening market, Revenue in Saliva-based Screening Business (2017-2022) & (US$ Million) introduction, recent developments, etc.

The major vendors covered:

Thermo Fisher scientific

Qiagen

Hologic

Takara Bio Inc

Arcis Biotechnology Limited

GeneProof

Abacus ALS

Chai Inc.

Kolplast Group

Lucence Health INc

Vitagene

Therma Bright Inc

ACON Laboratories, Inc

TODA PHARMA

Norgen Biotek Corp.

Assure Tech. (Hangzhou) Co., Ltd

Beijing Hotgen Biotech Co., Ltd

Nantong Diagnos Biotechnology Co., Ltd

NeuMoDx Molecular, Inc.

KYODO INTERNATIONAL INC.

Canvax

Zymo Research Corporation.

Salimetrics

NEST Scientific USA

Miraclean Technology Co. Ltd

Mawi DNA Technologies

Cell Projects Ltd.